The purpose of this collaborative CTSA (Clinical and Translational Science Award) application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in breastfeeding mothers and their infants
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Look at genetic factors predisposing patients to immediate postoperative opioid-adverse effects Respiratory Depression (RD) and Postoperative Nausea and Vomiting (PONV)
Timeframe: Immediately post-surgery during hospital stay
Look at genetic factors predisposing patients to immediate postoperative opioid-adverse effects Respiratory Depression (RD) and Postoperative Nausea and Vomiting (PONV)
Timeframe: At home up to 1 year post-surgery
Look at genetic factors predisposing patients to inadequate surgical pain relief with oxycodone
Timeframe: Immediately post-surgery during hospital stay
Look at genetic factors predisposing patients to inadequate surgical pain relief with oxycodone
Timeframe: At home up to 1 year post-surgery